FTAC ZEUS ACQUISITION CORP. ANNOUNCES CHANGE OF SPECIAL MEETING DATE
14 December 2022 - 12:49PM
FTAC Zeus Acquisition Corp. (NASDAQ:ZING) (the “Company”), a
blank-check company formed for the purpose of acquiring or merging
with one or more businesses, today announced that the special
meeting of its stockholders (the “Special Meeting”) scheduled for
Wednesday, December 14, 2022, is being postponed to Wednesday,
December 21, 2022. The Company decided to postpone the
Special Meeting in light of the amount of redemption requests it
received in connection with the meeting. The Company does not
anticipate proceeding with the Special Meeting or the proposals to
be voted on therein if the related redemption requests would result
in the Company’s trust account having a remaining balance less than
approximately $125 million.
At the Special Meeting, stockholders will be asked to vote on
the following proposals: (1) a proposal to approve an amendment to
the Company’s amended and restated certificate of incorporation
(the “Charter”) to provide the Company’s Board of Directors (the
“Board”) with the right to accelerate the date by which the Company
must consummate an initial business combination from May 23,
2023 (or by August 23, 2023 if the Company has executed a
letter of intent, agreement in principle or definitive agreement
for its initial business combination, but has not completed such
business combination, by May 23, 2023) (the “Original
Termination Date”), to such earlier date as determined by the Board
(such date, the “Amended Termination Date”); provided that such
date cannot be earlier than sixty (60) days before the
Original Termination Date (the “Charter Amendment”) (the “Charter
Amendment Proposal”); (2) a proposal to approve an amendment to the
Investment Management Trust Agreement dated November 18, 2021, by
and between the Company and Continental Stock Transfer &
Trust Company, as trustee, to allow the trustee to liquidate the
trust account (the “Trust Account”) established in connection with
the Company’s initial public offering at such earlier time as may
be determined by the Company as set forth in the Charter Amendment
(the “Trust Amendment Proposal” and together with the Charter
Amendment Proposal, the “Proposals”); and (3) a proposal to approve
the adjournment of the Special Meeting to a later date, if
necessary, under certain circumstances, including, but not limited
to, for the purpose of soliciting additional proxies in favor of
the Charter Amendment Proposal and Trust Amendment Proposal, in the
event the Company does not receive the requisite stockholder vote
to approve the Proposals.
As a result of this change, the Special Meeting will now be held
at 11:00 a.m., Eastern Time, on Wednesday, December 21, 2022, via a
virtual meeting link
at https://www.cstproxy.com/ftaczeus/2022. Also, as a result
of this change, the Company has extended the deadline for holders
of the Company’s Class A common stock issued in the Company’s
initial public offering to submit their shares for redemption in
connection with the Proposals to Monday, December 19, 2022.
The Company plans to continue to solicit proxies from
stockholders during the period prior to the Special Meeting. Only
the holders of the Company’s Class A common stock and Class B
common stock as of the close of business on November 8, 2022, the
record date for the Special Meeting, are entitled to vote at the
Special Meeting.
Forward-Looking Statements
This press release includes forward-looking statements that
involve risks and uncertainties. Forward-looking statements are
statements that are not historical facts. Such forward-looking
statements are subject to risks and uncertainties, which could
cause actual results to differ from the forward-looking statements.
These forward-looking statements and factors that may cause such
differences include, without limitation, uncertainties relating to
the Company’s stockholder approval of the Proposals, its
inability to complete an initial business combination within the
required time period or, and other risks and uncertainties
indicated from time to time in filings with the Securities and
Exchange Commission (the “SEC”), including the Company’s Annual
Report on Form 10-K for the fiscal year ended December 31, 2021
under the heading “Risk Factors” and other documents the Company
has filed, or will file, with the SEC. Readers are cautioned not to
place undue reliance upon any forward-looking statements, which
speak only as of the date made. The Company expressly disclaims any
obligations or undertaking to release publicly any updates or
revisions to any forward-looking statements contained herein to
reflect any change in the Company’s expectations with respect
thereto or any change in events, conditions or circumstances on
which any statement is based.
Participants in the Solicitation
The Company and its directors, executive officers, other members
of management and employees, under SEC rules, may be deemed to be
participants in the solicitation of proxies from the
securityholders of the Company in favor of the approval of the
Proposals. Investors and security holders may obtain more detailed
information regarding the names, affiliations and interests of the
Company’s directors and officers in the definitive proxy statement
dated November 16, 2022 (the “Proxy Statement”), which may be
obtained free of charge from the sources indicated below.
No Offer or Solicitation
This Press Release shall not constitute a solicitation of a
proxy, consent or authorization with respect to any securities or
in respect of the Proposals. This communication shall also not
constitute an offer to sell or the solicitation of an offer to buy
any securities, nor shall there be any sale of securities in any
states or jurisdictions in which such offer, solicitation or sale
would be unlawful prior to registration or qualification under the
securities laws of any such jurisdiction. No offering of securities
shall be made except by means of a prospectus meeting the
requirements of Section 10 of the Securities Act of 1933, as
amended, or an exemption therefrom.
Additional Information and Where to Find It
The Company urges investors, stockholders and other interested
persons to read the Proxy Statement as well as other documents
filed by the Company with the SEC, because these documents will
contain important information about the Company and the Proposals.
Stockholders may obtain copies of the Proxy Statement, without
charge, at the SEC’s website at www.sec.gov or by
directing a request to the Company’s proxy solicitor, Morrow
Sodali LLC, at 333 Ludlow Street, 5th Floor, South Tower, Stamford,
Connecticut 06902, ZING.info@investor.morrowsodali.com.
COMPANY CONTACT
FTAC Zeus Acquisition Corp. info@cohencircle.com
FTAC Zeus Acquisition (NASDAQ:ZINGU)
Historical Stock Chart
From Nov 2024 to Dec 2024
FTAC Zeus Acquisition (NASDAQ:ZINGU)
Historical Stock Chart
From Dec 2023 to Dec 2024